The health system attributed the 5.6% decline to continued rising labor and benefits costs as well as increased costs of supplies and pharmaceuticals, according to the report
First half revenue increased 2.1% to $3.3 billion, according to the report. Operating expenses increased 2.3% to $3.3 billion.
McLaren saw a $57.7 million increase in salaries, wages and benefits and payroll taxes, which increased 6.2% and 10% respectively. McLaren said the increases resulted mainly from pay increases, locum tenens physicians, and additional physicians onboarded in 2023. Supply costs increased 10.8% to $422.5 million, due to a combination of manufacturer price increases and increased volume of oncology and surgical patients compared to the prior year.
Net patient service revenue increased 6.7% year over year, according to the report. The system attributed the increases in inpatient discharges, observation cases, emergency room visits, and surgical procedures.
Premium revenue decreased 3% from the same period last year to $1.5 billion. The decrease was attributed due to a year-over-year decrease in members as the Medicaid determination process continued in Indiana and Michigan.
After accounting for nonoperating items such as investment returns, McLaren ended the half with a net gain of $321.5 million, up 21.3% year over year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
